AI-based Drug Design and Development in the Cloud

Cloud Pharmaceuticals is a leader in the burgeoning field of Artificial Intelligence based drug discovery and development.  The company partners, designs, develops, and licenses novel drug compounds for a wide range of medical indications to the pharmaceutical, biotechnology and medical research markets.  Novel drugs are developed through vertical holdings, typically LLCs for specific therapeutic areas.

The company launched in 2011 with a technology license from Duke University, and has since expanded through early stage funding arrangements from Microsoft, the National Science Foundation, and the University of Florida via its Gatorade royalty fund, and has established collaborations with Glaxosmithkline (“GSK”) and Fujitsu.  The company is currently raising its Series B round to further development of several programs.